| 000 | 01030 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250513061225.0 | ||
| 264 | 0 | _c19930617 | |
| 008 | 199306s 0 0 eng d | ||
| 022 | _a0278-2677 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRospond, R M | |
| 245 | 0 | 0 |
_aSargramostim for sulfasalazine-induced agranulocytosis. _h[electronic resource] |
| 260 |
_bClinical pharmacy _cMar 1993 |
||
| 300 |
_a179 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAgranulocytosis _xchemically induced |
| 650 | 0 | 4 |
_aDrug Eruptions _xetiology |
| 650 | 0 | 4 |
_aFever _xchemically induced |
| 650 | 0 | 4 |
_aGranulocyte-Macrophage Colony-Stimulating Factor _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPruritus _xchemically induced |
| 650 | 0 | 4 |
_aRecombinant Proteins _xtherapeutic use |
| 650 | 0 | 4 |
_aSulfasalazine _xadverse effects |
| 700 | 1 | _aGlowacki, R C | |
| 700 | 1 | _aMailliard, J A | |
| 773 | 0 |
_tClinical pharmacy _gvol. 12 _gno. 3 _gp. 179 |
|
| 999 |
_c8097601 _d8097601 |
||